Company claims that app adheres to government regulations and guidelines like UCPMP
GlobalSpace Technologies has launched of DocExa, ‘an exclusive digital platform developed using AI technology to help doctors efficiently manage their patients and other engagements,’ at a recent industry event.
DocExa reportedly leverages artificial intelligence, cloud and mobility technology to empower doctor, patients and pharma companies for meaningful and transparent engagement. Built on the latest AI algorithms, the app is cross-platform and can be accessed through a smartphone or a tab at any time and pace.
DocExa helps create a transparent engagement between the doctor and pharma communities, while adhering to the government regulations and guidelines like UCPMP. Additionally, doctors can file ADR through DocExa which provides real-time access of adverse drug reactions reports to Pharmaceutical companies and helps them to improve the quality of drugs. Doctors can also avail medico-legal consulting from a team of trusted, verified and reputed legal advisors, with the help of just a click or a tap.
Today 60 per cent of India’s population lies in tier two or three states. With greater penetration of mobility and growing number of Internet users in rural India, pharma companies will be able to expand their reach to connect with increasing number of doctors through the DocExa platform, according to a release. Leveraging technology, doctors based in rural areas will be able to stay updated with the latest medical advancements and drug brands in the market, creating a win-win for the entire industry.
Speaking at the launch, Krishna Singh, Founder, CMD, GlobalSpace Technologies said, “DocExa is the industry’s first AI driven Doctor-Pharmaceutical-Patient Connect Platform. In India, the doctor- patient ratio is still abysmally low at 1:1700. In its evolved form DocExa can enable doctors to carry out differential diagnostics and help more number of patients, efficiently.” He further added, “With the help of DocExa, we plan to connect over half a million doctors & 10 million patients by 2019.”